Cargando…
Neutrophil Cells Are Essential for The Efficacy of a Therapeutic Vaccine against Paracoccidioidomycosis
Paracoccidioidomycosis (PCM), caused by the Paracoccidioides species, is a systemic disease endemic in several Latin American countries, mainly in Brazil, Colombia, Argentina, and Venezuela. Current treatment approaches are challenging as they require prolonged durations of antifungal drugs that hav...
Autores principales: | Dias, Lucas dos Santos, Silva, Leandro B. R., Nosanchuk, Joshua D., Taborda, Carlos Pelleschi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226764/ https://www.ncbi.nlm.nih.gov/pubmed/34073466 http://dx.doi.org/10.3390/jof7060416 |
Ejemplares similares
-
Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
por: Santos Júnior, Samuel Rodrigues Dos, et al.
Publicado: (2023) -
Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis
por: Rittner, Glauce M. G., et al.
Publicado: (2012) -
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE
AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS
por: TABORDA, Carlos. P., et al.
Publicado: (2015) -
Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
por: Silva, Leandro B. R., et al.
Publicado: (2017) -
Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis
por: de Araújo, Marcelo Valdemir, et al.
Publicado: (2020)